Livzon Pharmaceutical Group (HKSE:01513) Short-Term Debt : HK$2,621 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Livzon Pharmaceutical Group Short-Term Debt?

Livzon Pharmaceutical Group's Short-Term Debt for the quarter that ended in Dec. 2024 was HK$2,621 Mil.

Livzon Pharmaceutical Group's quarterly Short-Term Debt increased from Jun. 2024 (HK$1,992 Mil) to Sep. 2024 (HK$2,257 Mil) and increased from Sep. 2024 (HK$2,257 Mil) to Dec. 2024 (HK$2,621 Mil).

Livzon Pharmaceutical Group's annual Short-Term Debt increased from Dec. 2022 (HK$1,812 Mil) to Dec. 2023 (HK$2,034 Mil) and increased from Dec. 2023 (HK$2,034 Mil) to Dec. 2024 (HK$2,621 Mil).

Livzon Pharmaceutical Group Short-Term Debt Historical Data

The historical data trend for Livzon Pharmaceutical Group's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Short-Term Debt Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

1,838.54

2,501.65

1,811.58

2,034.44

2,621.14

Livzon Pharmaceutical Group Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															2,034.44	1,477.38	1,991.61	2,257.14	2,621.14

Livzon Pharmaceutical Group Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Livzon Pharmaceutical Group Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (HKSE:01513) » Definitions » Short-Term Debt

Traded in Other Exchanges

LP6:Germany 000513:China

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment in PRC which is pharmaceutical manufacturing.

Executives

Zhu Baoguo

2201 Interest of corporation controlled by you

Livzon Pharmaceutical Group Headlines

No Headlines